This trial looks at how digital devices can help kids with ADHD manage symptoms and improve their functioning.
1 Primary · 3 Secondary · Reporting Duration: Change from Baseline to Post-intervention (4 weeks)
3 Treatment Groups
1 of 3
1 of 3
1 of 3
150 Total Participants · 3 Treatment Groups
Primary Treatment: FRx-004 · No Placebo Group · N/A
Who is running the clinical trial?
Age 8 - 12 · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is this study recruiting individuals aged 35 and younger?
"This medical trial is looking for children that are between 8 and 12 years old." - Anonymous Online Contributor
Are there still places available to join this research endeavor?
"According to the clinicaltrials.gov listing, this medical study is actively collecting participants at present. The research was first submitted on February 15th 2023 and its details were revised most recently that same day." - Anonymous Online Contributor
What is the total enrollment number for this investigation?
"Correct. Data published on clinicaltrials.gov confirms that this medical study, which was posted initially on February 15th 2023 is actively enrolling participants. 150 patients are needed from 1 research centre." - Anonymous Online Contributor
Is participation in this clinical experiment open to the public?
"This clinical trial is targeting 150 minors aged 8-12 who have been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). All participants must be located in the United States, able to understand and read English at grade level either independently or with adult assistance. Additionally, all youth participating are required to wear a device on their wrist for four weeks during school hours from Monday through Friday. The eligibility criteria includes an ADHD Rating Scale version 5 total score of 28 or greater as determined by parent ratings on the baseline questionnaire; however, those scoring below this threshold may participate but will not included in per protocol analyses." - Anonymous Online Contributor